Literature DB >> 19209100

An office-based prospective study of deafness in mumps.

Hiromi Hashimoto1, Masashi Fujioka, Hiroshi Kinumaki.   

Abstract

BACKGROUND: Deafness is a rare but important complication of mumps virus infection. Its incidence has been estimated at 0.5 to 5.0 per 100,000 cases of mumps, but recent reports from Japan, where mumps is endemic, suggest that the incidence might be higher.
OBJECTIVE: Prospective office-based study to determine the incidence of hearing loss in children with mumps.
METHODS: Forty pediatric practices participated in this survey. The study population consisted of patients < or =20 years old with mumps seen between January 2004 and December 2006. Clinical diagnosis of mumps was made by experienced pediatricians. Among those from whom written consent was obtained, parents were asked to conduct hearing screening tests by rubbing fingers near the ears twice daily for 2 weeks. Patients suspected with hearing loss were further examined by an otolaryngologist.
RESULTS: Among 7400 children who underwent hearing ability assessment after clinical onset of mumps, 7 had confirmed hearing loss; none had been previously vaccinated against mumps. In all cases, hearing loss was unilateral but severe and did not improve over time.
CONCLUSIONS: The incidence of hearing loss in children due to mumps was 7/7400 (approximately 1/1000 cases), which is higher than previously suggested. Prevention of deafness is another important reason for assuring universal immunization against mumps.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19209100     DOI: 10.1097/INF.0b013e31818a8ca8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus.

Authors:  Marie Kubota; Rei Matsuoka; Tateki Suzuki; Koji Yonekura; Yusuke Yanagi; Takao Hashiguchi
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 2.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 3.  Molecular biology, pathogenesis and pathology of mumps virus.

Authors:  Steven Rubin; Michael Eckhaus; Linda J Rennick; Connor G G Bamford; W Paul Duprex
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 4.  Vaccine chronicle in Japan.

Authors:  Tetsuo Nakayama
Journal:  J Infect Chemother       Date:  2013-07-09       Impact factor: 2.211

5.  Static model simulation for routine mumps vaccination in Japan: with a result of mumps-related complications in a Japanese community hospital.

Authors:  Taito Kitano; Masayuki Onaka; Mariko Ishihara; Atsuko Nishiyama; Naoki Hashimoto; Sayaka Yoshida
Journal:  Clin Exp Vaccine Res       Date:  2017-07-26

6.  The potential dysfunction of otolith organs in patients after mumps infection.

Authors:  Yu-Juan Zhou; Jing Yu; Yong-Zhen Wu; Liang Tian; Zhao Han; Jing Wang; Fang-Lu Chi
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

7.  Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Authors:  Tetsuo Nakayama; Masahiro Eda; Motonori Hirano; Wakako Goto
Journal:  Hum Vaccin Immunother       Date:  2019-04-22       Impact factor: 3.452

8.  Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012.

Authors:  Jussi Sane; Sigrid Gouma; Marion Koopmans; Hester de Melker; Corien Swaan; Rob van Binnendijk; Susan Hahné
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

Review 9.  Viral causes of hearing loss: a review for hearing health professionals.

Authors:  Brandon E Cohen; Anne Durstenfeld; Pamela C Roehm
Journal:  Trends Hear       Date:  2014-07-29       Impact factor: 3.293

Review 10.  Unique Tropism and Entry Mechanism of Mumps Virus.

Authors:  Marie Kubota; Takao Hashiguchi
Journal:  Viruses       Date:  2021-09-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.